Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, North Carolina, USA.
Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA.
Clin Microbiol Infect. 2022 Jun;28(6):779-784. doi: 10.1016/j.cmi.2022.02.005. Epub 2022 Feb 18.
The COVID-19 pandemic has influenced the field of solid organ transplantation (SOT) in many ways. COVID-19 has led to programmatic impacts and changes in donor and recipient selection. Several studies have evaluated the course, optimal treatment, and prevention of COVID-19 in SOT recipients.
To review the literature on COVID-19 in SOT recipients.
PubMed, Web of Science, and Google Scholar were searched. The search was restricted to articles published between January 1, 2019 and December 1, 2021.
The COVID-19 pandemic initially led to a decreased volume of solid organ transplants. However, transplant volumes at most centres have rebounded. Donor selection remains an incompletely defined issue. Several reports suggest that donor-derived SARS-CoV-2 infections occur only in lung transplant recipients and that other organs from SARS-CoV-2 PCR-positive donors could potentially be safely used. However, these data are limited to case series. Transplantation for end-stage lung disease after COVID-19 infection is increasingly common and has been performed with acceptable outcomes. In acute COVID-19 in a transplant candidate, transplantation should be delayed when feasible. After adjustment, mortality after COVID-19 appear similar in SOT recipients compared to the general population, with notable increased use of antiviral and anti-inflammatory treatment options. Prevention of COVID-19 is key in SOT recipients. Vaccination of SOT recipients and anyone who is in contact with SOT recipients is one of the cornerstones of prevention. Nonpharmacological interventions such as face coverings, hand hygiene, and physical distancing remain ever important as well.
The COVID-19 pandemic continues to have an important impact on SOT candidates and recipients. Prevention of infection is the most important measure and requires careful attention to approaches to vaccination and messaging of the ongoing need for face coverings, physical distancing, and hand hygiene.
COVID-19 疫情以多种方式影响了实体器官移植(SOT)领域。COVID-19 导致了项目的影响和供体与受体选择的改变。有几项研究评估了 SOT 受者 COVID-19 的病程、最佳治疗和预防。
综述 SOT 受者 COVID-19 的文献。
检索了 PubMed、Web of Science 和 Google Scholar。检索仅限于 2019 年 1 月 1 日至 2021 年 12 月 1 日期间发表的文章。
COVID-19 大流行最初导致实体器官移植数量减少。然而,大多数中心的移植量已经反弹。供体选择仍然是一个未完全定义的问题。有几项报告表明,只有肺移植受者才会发生供体来源的 SARS-CoV-2 感染,而来自 SARS-CoV-2 PCR 阳性供体的其他器官可能可以安全使用。然而,这些数据仅限于病例系列。COVID-19 感染后终末期肺病的移植越来越常见,并且已经取得了可接受的结果。在移植候选者的急性 COVID-19 中,在可行的情况下应延迟移植。调整后,SOT 受者的 COVID-19 死亡率与一般人群相似,抗病毒和抗炎治疗选择的使用明显增加。SOT 受者的 COVID-19 预防是关键。SOT 受者和任何与 SOT 受者接触的人的疫苗接种是预防的基石之一。非药物干预,如口罩、手部卫生和保持身体距离仍然非常重要。
COVID-19 大流行继续对 SOT 候选者和受者产生重要影响。预防感染是最重要的措施,需要仔细注意疫苗接种方法以及关于持续需要戴口罩、保持身体距离和手部卫生的信息传递。